C12Y 101/0106
2-hydroxy-3-oxopropionate reductase
Official title: 2-Hydroxy-3-oxopropionate reductase (1.1.1.60)
C12Y101/0106 (2-hydroxy-3-oxopropionate reductase) appears on 4 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 6
- Assignees
- 4
- Inventors
- 28
- Latest grant
- 27 Apr 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 2 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Secretagogues derived from oxalobacter formigenes27 Apr 2021US 10,988,510 B2Oxthera Intellectual Property AB
- Secretagogues derived from oxalobacter formigenes13 Nov 2018US 10,125,176 B2Oxthera Intellectual Property AB
- Microorganism having carbon dioxide fixation cycle introduced thereinto28 Nov 2017US 9,828,618 B2Mitsui Chemicals, Inc.
- Microorganism having carbon dioxide fixation pathway introduced thereinto21 Nov 2017US 9,822,387 B2Mitsui Chemicals, Inc.
- Genetically Engineered Yeast Producing 3-Hydroxypropionic Acid at Low pH7 May 2026US 2026/0125634 A1Archer Daniels Midland Company
- Secretagogues derived from oxalobacter formigenes31 Mar 2022US 2022/0098247 A1Oxthera Intellectual Property AB
- Secretagogues derived from oxalobacter formigenes21 Mar 2019US 2019/0085035 A1Oxthera Intellectual Property AB
- Secretagogues derived from oxalobacter formigenes19 May 2016US 2016/0137701 A1Oxthera Intellectual Property AB
- Microorganism having carbon dioxide fixation cycle introduced thereinto20 Aug 2015US 2015/0232903 A1Mitsui Chemicals, Inc.
Most cited
By later US patents